Skip Navigation

Skip Navigation

Issue No. 40  | September 18, 2012
View HTML version

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Globe of the earth

HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Issues Statement on Use of Elvitegravir/Cobicistat/Tenofovir/Emtricitabine

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents recommends elvitegravir (EVG)/cobicistat (COBI)/tenofovir (TDF)/emtricitabine (FTC) as an alternative regimen for ART-naive patients. The fixed-dose combination product was recently approved by FDA. The Panel’s statement on use of EVG/COBI/TDF/FTC includes clinical trial and safety data on this combination product.


Twitter - Stay connected FaceBook - Stay connected
ClinicalTrials.gov Info

Subscribe Info

Contact AIDSinfo
Download Adobe Acrobat(R) Reader TM to view PDF files located on this site.
ISSN 1558-3228